Ritsuzo Kozuka

7PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumoursAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2026
Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan.

|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.

Rui Huang, Ai-Thien Do, Hidenori Toyoda

|Oct 25, 2021
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment.

Hiroko Ikenaga, Sawako Uchida-Kobayashi, Akihiro Tamori

|Oct 23, 2021
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.

Chung-Feng Huang, Tyng-Yuan Jang, Dae Won Jun

|Aug 31, 2018
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment.

Ritsuzo Kozuka, Masaru Enomoto, Misako Sato-Matsubara

|Dec 24, 2017
The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort.

R Kozuka, H Hai, H Motoyama

Pageof 2

Frequent Collaborators

2 joint publications

Akihiro Tamori

2 joint publications

Chung-Feng Huang

2 joint publications

Eiichi Ogawa

2 joint publications

Ming-Lung Yu